Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $3.27 Million - $3.66 Million
-44,453 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $3.21 Million - $4.02 Million
44,453 New
44,453 $3.41 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $10.6 Million - $12.4 Million
-208,915 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $852,091 - $1.02 Million
-16,507 Reduced 7.32%
208,915 $11.8 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $13.2 Million - $14.2 Million
225,422
225,422 $14.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Uniplan Investment Counsel, Inc. Portfolio

Follow Uniplan Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.